(3-Phenoxyphenyl)methanol

We are (3-Phenoxyphenyl)methanol CAS:13826-35-2 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

CAS No: 13826-35-2
Product Name: (3-Phenoxyphenyl)methanol
Other Name:
(3-Phenoxyphenyl)methanol
3-(Hydroxymethyl)diphenyl Ether
3-Phenoxybenzyl alcohol
 
Density: 1.2±0.1 g/cm3
Boiling Point: 377.8±0.0 °C at 760 mmHg
Melting Point: 4-7°C
Molecular Formula: C13H12O2
Molecular Weight: 200.233
Flash Point: 151.3±17.4 °C
Exact Mass: 200.083725
PSA: 29.46000
LogP: 3.03
Vapour Pressure: 0.0±0.9 mmHg at 25°C
Index of Refraction: 1.596
Stability: Stable. Combustible. Incompatible with strong oxidizing agents.
 
Specification
Appearance: Colorless or light yellow liquid 
Assay: ≥99.0%
Loss on drying: ≤0.5%
 
Application
Intermediates of Ethofenprox CAS: 80844-07-1.
Intermediates of Phenothrin CAS: 26002-80-2.
Intermediates of Permethrin CAS: 52645-53-1.
Be used as pesticide intermediate, mainly used in the synthesis of insecticide.
 
Package: 25kg/drum, can also be designed according to customer requirements.
Storage: Store in cool place. Keep container tightly closed in a dry and well-ventilated place.

(3-Phenoxyphenyl)methanol


Related News: Any drug or medication is composed of two components.150255-96-2 Using a proprietary chemistry platform, Onconova has created a pipeline of targeted agents designed to work against specific cellular pathways that are important in cancer cells.11,11-dimetil-5,11-dihidroindeno [1,2-b] carbazol CAS:1260228-95-2 Using a proprietary chemistry platform, Onconova has created a pipeline of targeted agents designed to work against specific cellular pathways that are important in cancer cells.92-15-9 Trial results demonstrated that Oligomannate statistically improved cognitive function in mild-to-moderate AD patients as early as week 4 and the benefit was sustained at each follow-up assessment visit,” Shanghai Green Valley Pharmaceuticals, which developed the drug along with two academic institutions in China, said in a statement.Trial results demonstrated that Oligomannate statistically improved cognitive function in mild-to-moderate AD patients as early as week 4 and the benefit was sustained at each follow-up assessment visit,” Shanghai Green Valley Pharmaceuticals, which developed the drug along with two academic institutions in China, said in a statement.

Related Products
Product Name
methyl 2-[(4-methylphenyl)sulfonylamino]acetate View Details
5-(2,4,6-trimethylphenyl)cyclohexane-1,3-dione View Details
(1R)-1-phenylethanamine View Details
2-Amino-N-cyclohexyl-N-methylbenzenesulfonamide manufacturer Dimethoxymethylphenylsilane manufacturer 2-Bromobutyric acid methyl ester manufacturer cyclobutanecarbaldehyde manufacturer 3-Borono-5-fluorobenzoic acid manufacturer